Introduction: Non-melanoma skin cancer is among the most frequent neoplasms in Brazil and is deemed a public health problem. Initial diagnosis is based on clinical suspicion and includes dermoscopy. Confirmation is carried out via histological analysis. Dermoscopy also contributes to the demarcation of tumor safety margins. Objective: To analyze the accuracy of dermoscopy in the diagnosis of non-melanoma skin cancer and its effectiveness in defining the lateral margins of these tumors in excisional biopsies.
RESU MO

RESULTS
Seventy skin lesions were analyzed with diagnostic hypothesis (DH) of NMSC in a group of 50 patients, 27 being male (54%) and 23 female (46%) with a mean age of 70 years (Table 1) . Of these data, the DH of BCC represented 70% and of SCC, 30%.
The diagnostic accuracy rate for BCC was of 79.6%, and for SCC, 23.8% (Table 2) . Table 3 shows the other histologic diagnoses found, that do not correspond to the clinical hypothesis of BCC. Table 4 shows other histologic diagnoses found that do not correlate with the clinical hypothesis of SCC.
Regarding the body location, the most affected areas were head and neck, followed by upper limbs and hands ( Table 5 ). The area more prevalent for BCC was the head and neck (63%), and for SCC, upper limbs (48%).
Of the accurate BCC diagnoses, 74% had surgical margins clear of malignancy, compared to 60% of SCC. There was no description of the surgical margins in seven BCC lesions and one SCC lesion (Graph 1).
(70% to 20%, 3,5 relationship). 6 Regarding the results found, the proportion of BCC to SCC was of 39:8 or 4.875. Therefore, in this study, there was a higher relative prevalence of BCC compared to SCC in the histologic results.
In this study, we observed that the accuracy rate for BCC was higher than for SCC. This finding can be explained based on the more specific dermoscopic features for the former, com-
INTRODUCTION
Non-melanoma skin cancer (NMSC) is among the most common malignancies, occurring more than the other types of cancers combined, 1, 2 therefore being a public health issue due to its increasing incidence and to the consequent costs associated with treatment. 3 Tumors that are representative for NMSC are basal cell carcinomas (BCC) and squamous cell carcinomas (SCC), [4] [5] [6] the latter representing about 20% of skin cancer cases and the former approximately 70%. 6 In general, they cause more morbidity than mortality, but both have the potential to metastasize (0.5% for BCC and 20% for SCC). 7 Diagnostic suspicion of these tumors starts with the clinical aspect and is aided by dermoscopic features. 8 BCC's dermoscopy can present with the following signs, with high specificity: "spoke wheel" areas, large blue-grey ovoid nests, multiple blue-grey globules, "leaf-like" areas (or in "gloved finger"), arborizing telangiectasias and ulcerations (less specific). 9 SCC's is usually not that specific as to differentiate it from the early variants (actinic keratosis and Bowen disease) and, in some cases, even other entities such as seborrheic keratoses, verruca vulgaris, and keratoacanthomas. Glomerular vessels and yellow-white areas are dermoscopic findings in SCC. 10, 11 The gold-standard for the diagnosis of NMSC, either BCC or SCC, is histopathology. 5 There are, however, non-invasive methods to examine the lesions in an initial phase and stratify their risk, dermoscopy being one of them. 12, 13 Its importance consists in the necessity to minimize costs with unnecessary biopsies, define the physician's attitude towards the patient and, in some cases, reduce surgical morbidity. On the other hand, dermoscopy contributes for the early diagnosis (early or small lesions) and appropriate treatment (determination of surgical margins). These are key-factors for a more favorable prognosis for NMSC. 14 The objective of the study is to perform a self-assessment of an academic service of the Brazilian Society of Dermatology (SBD) regarding the clinical-dermoscopic accuracy rates for NMSC and analyze the degree of efficacy of the excisional biopsy in avoiding an incisional step considering the cases accurate for NMSC.
METHOD
Study conducted at the service of dermatology, Universidade de Mogi das Cruzes, São Paulo, Brazil, from 2015 to 2017, where 70 suspicious lesions for NMSC were evaluated in a group with 50 patients.
Inclusion criteria for the lesions were low-risk NMSC (up to 1cm and well-defined) and prediction of non-complex reconstruction, i.e., edge-edge closure to enable wider excision in case of affected margins. The lateral margin used was 3mm and the deep margin was down to the subcutaneous tissue, with the scalpel at a 90º angle in relation to the skin.
Exclusion criteria were tumors larger than 1cm, ill-defined, recurrences and periorificial.
The lesions were registered in a database with the following information: diagnostic hypothesis, age, gender, and area Misdiagnosis is suspected BCCs can be explained by some factors: non-specific clinical features and dermoscopic vascular features similar in some cases of BCC, KA and SCC; even though possible, the dermoscopic differentiation 17 demands a higher experience of the assistant physicians in the dermoscopy learning curve. Operator-dependent (pathologist) or even laboratory logistic (wrong slides or reports) errors must be considered.
Regarding the surgical margins, we observed that they were insufficient in some cases of NMSC, taking into consideration a 3mm excision from the outer limits of the tumor, dermoscopically marked, with a higher relevance for SCC, justifying larger safety margins than the medical literature recommends for this tumor, compared to BCC.
One possible explanation is the commonly ill-defined limits of SCCs, besides accompanying inflammation.
We should include possible operator-dependent-type biases of the histopathology. Many reports were inconclusive regarding the margins.
CONCLUSION
NMSC diagnosis depends on consistent and well sound information, using clinical, dermoscopic and, specially, histopathologic criteria. The accuracy of the first two depends largely on the experience of the dermatologist, and the third of a pathologist experienced in skin and, if possible, skin tumors. More than that, the interaction between the two professionals is extremely important.
In tertiary cutaneous oncology services, the assistant dermatologist should specify the type of biopsy (incisional x excisional) and the characteristics that lead to the clinical suspicion, so that the pathologist can fulfill their role with equal accuracy.
